explore -WSS

explore

author：focus 2025-09-30 12:18:49 - browse：71662

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Driven by the pandemic, applicants flood public health schools

explore

WSS

Google's generative AI to analyze medical images — and talk to docs

Affordable Connectivity Program vital to health care, experts say

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Indian pharmaceutical industry in denial over drug

Election results set back Medicaid expansion plans

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Sports medicine is finally prioritizing gender equality

With heat waves through August, officials warn of health risks

At least 13 dead in Texas as scorching temps continue

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Duchenne breakthrough therapy leaves behind pioneering families

Tesla recalling nearly 16,000 of its 2021

Tori Bowie and the unacceptable rates of Black maternal death

Election results set back Medicaid expansion plans

entertainment

It was time to plan for my old age. If only I could stop crying

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

NFL doctors' conflicts of interest could endanger players, report says

Ending racial health disparities hinges on penalties, political will

Stanford president's case begs question: Who takes blame?

Slovenia has suffered its worst

focus

explore

leisure time

focus